Ariella Golomb
Partner & Founder @ InnovaHealth Partners
New York, United States
Ariella Golomb is a Series B investor at InnovaHealth Partners in New York focused on Medical and Health Care. Ariella Golomb is the Partner and Founder at InnovaHealth Partners.Dr. Golomb brought expertise in medicine and strategy to HealthpointCapital. She was a member of the Firm’s investment team, manages both the firm’s Scientific Advisory Board and other clinical relationships and oversees the operations of the firm. Prior to joiningHealthpointCapital, Dr. Golomb was a Project Leader for the Health Care Practice of the Boston Consulting Group, where she advised global life science companies on strategic management issues including product positioning, sales force restructuring and academic medical center alliances. While in business school, Dr. Golomb worked at Wyeth Pharmaceuticals in the Women’s Health Marketing division.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Ariella Golomb invests in
Stages Ariella Golomb invests in
Countries Ariella Golomb invests in
Investment Focus
Industry
- Medical 2 (50%)
- Health Care 2 (50%)
- Hospital 1 (25%)
- Medical Device 1 (25%)
Stage
- Series B 1 (25%)
- Series E 1 (25%)
- Private Equity 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Materna Medical
|
Materna Medical is a novel OBGYN platform company defining a $6B market with core technologies addressing unmet needs in women's pelvic health. With headquarters in Mountain View, California, Materna pulls from the top minds in MedTech to truly transform the standard of care in OBGYN. With a diverse team of engineers, scientists, researchers,and commercial leaders, Materna Medical’s mission is to empower women to protect their pelvic health. | $5M / Series B / Jul 01, 2026 | |
Route 92 Medical
|
Route 92 Medical is a developer of a stealthy catheter for stroke treatment. The company was founded in 2015 and based in San Mateo, California. | $50M / Private Equity / Apr 07, 2026 | |
|
Materna Medical
|
Materna Medical is a novel OBGYN platform company defining a $6B market with core technologies addressing unmet needs in women's pelvic health. With headquarters in Mountain View, California, Materna pulls from the top minds in MedTech to truly transform the standard of care in OBGYN. With a diverse team of engineers, scientists, researchers,and commercial leaders, Materna Medical’s mission is to empower women to protect their pelvic health. | $20M / Series B / May 21, 2024 | |
|
Route 92 Medical
|
Route 92 Medical is a developer of a stealthy catheter for stroke treatment. The company was founded in 2015 and based in San Mateo, California. | $56M / Series E / Dec 14, 2021 |
Co-Investors
About InnovaHealth Partners
InnovaHealth Partners is an investment firm concentrating on growth buyouts of late stage medical technology companies.
InnovaHealth Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Ariella Golomb
Partner & Founder
|
|||
John C. McCormick
Managing Director
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Ariella Golomb invest in?
Ariella Golomb invests primarily in Medical, Health Care and Hospital startups, most often at Series B and Series E stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Ariella Golomb last invest?
The most recent investment recorded for Ariella Golomb closed in Jul 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
